🕵️ Moonlake Immunotherapeutics ($MLTX)
SEC insider & ownership activity, last 12 months · CIK 1821586 · every row links its SEC filing
Over the last 12 months insiders sold $129.9M against $99K of open-market buying. BVF Partners L P/IL sold $63.0M in discretionary trades (Mar). BVF Partners L P/IL trimmed 22.3% → 19.7%; BVF INC/IL trimmed 22.3% → 19.7%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $99K (1 lots) · 5 sellers, $129.9M (31 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| BVF Partners L P/IL | 0 | – | 3 | $63.0M | Mar 31, 2026 |
| Chen Bihua | 0 | – | 5 | $46.9M | Sep 30, 2025 |
| Santos Da Silva Jorge | 0 | – | 7 | $8.7M | Jul 10, 2026 |
| Reich Kristian | 0 | – | 9 | $8.1M | Jul 22, 2026 |
| Bodenstedt Matthias | 1 | $99K | 7 | $3.2M | Jun 22, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BVF Partners L P/IL | 19.7% | 13D | Jun 25, 2026 | filing ↗ | |
| BVF INC/IL | 19.7% | 13D | Jun 25, 2026 | filing ↗ | |
| Mark N. Lampert | 19.7% | 13D | Jun 25, 2026 | filing ↗ | |
| BVF GP Holdings LLC | 18.4% | 13D | Jun 25, 2026 | filing ↗ | |
| Biotechnology Value Fund L P | 10.2% | 13D | Jun 25, 2026 | filing ↗ | |
| BVF I GP LLC | 10.2% | 13D | Jun 25, 2026 | filing ↗ | |
| Biotechnology Value Fund II LP | 8.1% | 13D | Jun 25, 2026 | filing ↗ | |
| BVF II GP LLC | 8.1% | 13D | Jun 25, 2026 | filing ↗ | |
| DEEP Track Capital, LP | 6.5% | 13G | Nov 12, 2025 | filing ↗ | |
| DEEP Track Biotechnology Master Fund, Ltd. | 6.5% | 13G | Nov 12, 2025 | filing ↗ | |
| David Kroin | 6.5% | 13G | Nov 12, 2025 | filing ↗ | |
| Cormorant Asset Management, LP | 6.2% | 13G | May 15, 2026 | filing ↗ | |
| Bihua Chen | 6.2% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Reich Kristian | $2.9M | Jul 15, 2026 | filing ↗ |
| Santos Da Silva Jorge | $3.0M | Jun 30, 2026 | filing ↗ |
| Reich Kristian | $2.9M | Jun 15, 2026 | filing ↗ |
| Jorge Pedro Santos Radeck D Silva | $2.8M | Apr 10, 2026 | filing ↗ |
| Bodenstedt Matthias | $3.0M | Apr 9, 2026 | filing ↗ |
| BVF Partners L P/IL | $63.5M | Mar 31, 2026 | filing ↗ |
| Jorge Pedro Santos Radeck DA Silva | $3.0M | Dec 8, 2025 | filing ↗ |
| Kristian Dieter Johannes Reich | $3.0M | Dec 8, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 14, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 21, 2026 | filing ↗ |
| Other events (8.01) | Jun 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 21, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 4, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 4, 2026 | filing ↗ |
| Material agreement (1.01) | May 22, 2026 | filing ↗ |
| Earnings (2.02) | May 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 10, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 18, 2026 | filing ↗ |
| Earnings (2.02) | Feb 18, 2026 | filing ↗ |
| New financial obligation (2.03) | Feb 18, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 18, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 18, 2026 | filing ↗ |
| Other events (8.01) | Feb 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 18, 2026 | filing ↗ |
| Other events (8.01) | Jan 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 8, 2026 | filing ↗ |
| Earnings (2.02) | Nov 5, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Other events (8.01) | Sep 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 29, 2025 | filing ↗ |
| Earnings (2.02) | Aug 5, 2025 | filing ↗ |